Sysnav
  • Home
  • Syde Platform
  • Clinical Research
  • Sysnav HealthCare
  • News & Events
  • Contact
SYSNAV Healthcare Announces EMA Primary Endpoint Qualification of Stride Velocity 95th Centile (SV95C) for Duchenne Muscular Dystrophy.
Learn More
  • Home
  • Syde Platform
  • Clinical Research
  • Sysnav HealthCare
  • News & Events
  • Contact
December 2022

ECTRIMS 2022

November 2022

SYSNAV sponsors the Angelman Syndrome Biomarkers & Outcome Measures Scientific Meeting

November 2022

SMA Europe – Oct 2022

October 2022

World Muscle Society 2022

October 2022

Study Results with SV95C real-world data – Solid Biosciences

July 2022

17th International Congress on Neuromuscular Diseases

Sysnav
  • Syde Platform
  • Clinical Research
  • Sysnav Healthcare
  • Contact

©Sysnav 2023, all rights reserved

Legal mentions

Privacy Policy

General Conditions of Use

Design : Adveris

This site uses cookies to guarantee you the best possible experience.

Accept Decline